{"id":155613,"date":"2023-11-01T08:56:06","date_gmt":"2023-11-01T12:56:06","guid":{"rendered":"https:\/\/44.250.171.167\/?p=155613"},"modified":"2023-11-01T08:56:08","modified_gmt":"2023-11-01T12:56:08","slug":"sun-pharmaceuticals-industries-ltd-q2fy24-6-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/sun-pharmaceuticals-industries-ltd-q2fy24-6-rise-in-profits\/","title":{"rendered":"Sun Pharmaceuticals Industries Ltd Q2FY24; 6% rise in Profits"},"content":{"rendered":"\n<p>Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. It is the largest pharmaceutical company in India.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Financial Results:<\/h2>\n\n\n\n<p>Sun Pharmaceuticals Industries Ltd reported Revenues for Q2FY24 of \u20b912,192.00 Crores up from \u20b910,952.00 Crore year on year, a rise of 11.32%.<\/p>\n\n\n\n<p>Total Expenses for Q2FY24 of \u20b99,695.00 Crores up from \u20b98,625.00 Crores year on year, a rise of 12.41%.<\/p>\n\n\n\n<p>Consolidated Net Profit of \u20b92,385.00 Crores up 5.72% from \u20b92,256.00 Crores in the same quarter of the previous year.<\/p>\n\n\n\n<p>The Earnings per Share is \u20b99.90, up 4.98% from \u20b99.43 in the same quarter of the previous year.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-8-839x1024.png\" alt=\"\" class=\"wp-image-155615\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-8-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-8-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-8-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-8-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-8.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/figure>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/app.asai.alphastreet.io\/test-drive\/dashboard?utm_source=IN_WordPress&amp;utm_medium=IN_WordPress&amp;utm_campaign=IN_WordPress&amp;utm_id=IN_WordPress\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"321\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/ASAI-Product-2.gif\" alt=\"\" class=\"wp-image-155601\"\/><\/a><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. It is the [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":155615,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[10304,12565,1115],"class_list":["post-155613","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-api","tag-generic-formulation","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-8.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":155200,"url":"https:\/\/alphastreet.com\/india\/torrent-pharmaceuticals-ltd-q2fy24-24-rise-in-profits\/","url_meta":{"origin":155613,"position":0},"title":"Torrent Pharmaceuticals Ltd Q2FY24; 24% rise in Profits","author":"Chirag Gupta","date":"October 23, 2023","format":false,"excerpt":"Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. Financial Results: Torrent Pharmaceuticals Ltd reported Revenues for Q2FY24 of \u20b92,660.00 Crores up from \u20b92,291.00 Crore year on year, a rise of 16.11%. Total Expenses for Q2FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-90.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-90.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-90.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-90.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-90.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-90.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157069,"url":"https:\/\/alphastreet.com\/india\/aurobindo-pharma-ltd-q2fy24-83-rise-in-profits\/","url_meta":{"origin":155613,"position":1},"title":"Aurobindo Pharma Ltd Q2FY24; 83% rise in Profits","author":"Divyansh_Kasana","date":"December 4, 2023","format":false,"excerpt":"Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. Financial Results: Aurobindo Pharma Ltd reported Revenues for Q2FY24 of \u20b97,219.00 Crores up from \u20b95,739.00 Crore year on year, a rise of 25.79%. Total Expenses for Q2FY24 of \u20b96,332.00 Crores up from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-25.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-25.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-25.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-25.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-25.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-25.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":156384,"url":"https:\/\/alphastreet.com\/india\/morepen-laboratories-ltd-q2fy24-31-rise-in-profits\/","url_meta":{"origin":155613,"position":2},"title":"Morepen Laboratories Ltd Q2FY24; 31% rise in Profits","author":"Hardik Bhandare","date":"November 17, 2023","format":false,"excerpt":"Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products. Financial Results: Morepen Laboratories Ltd reported Revenues for Q2FY24 of \u20b9422.00 Crores up from \u20b9403.00 Crore year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-236.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-236.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-236.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-236.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-236.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-236.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157523,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q2fy24-3-rise-in-profits\/","url_meta":{"origin":155613,"position":3},"title":"Alembic Pharmaceuticals Ltd Q2FY24; 3% rise in Profits","author":"Divyansh_Kasana","date":"December 21, 2023","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q2FY24 of \u20b91,595.00 Crores up from \u20b91,475.00 Crore year on year, a rise of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-168.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-168.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-168.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-168.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-168.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-168.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166559,"url":"https:\/\/alphastreet.com\/india\/sun-pharmaceuticals-industries-ltd-q3fy25-14-rise-in-profits\/","url_meta":{"origin":155613,"position":4},"title":"Sun Pharmaceuticals Industries Ltd Q3FY25; 14% rise in Profits","author":"Chirag Gupta","date":"January 31, 2025","format":false,"excerpt":"Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":156245,"url":"https:\/\/alphastreet.com\/india\/rpg-life-sciences-ltd-q2fy24-30-rise-in-profits\/","url_meta":{"origin":155613,"position":5},"title":"RPG Life Sciences Ltd Q2FY24; 30% rise in Profits","author":"Chirag Gupta","date":"November 15, 2023","format":false,"excerpt":"RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in the domestic and international market.The company is a part of RPG group which is a diversified conglomerate with interests in areas of infrastructure, tyres, information technology, pharmaceuticals, energy\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-192.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-192.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-192.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-192.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-192.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-192.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/155613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=155613"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/155613\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/155615"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=155613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=155613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=155613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}